RI-AG03
Product Specifications
Target
Microtubule Associated|||Others
Related Pathways
Others|||Cytoskeletal Signaling
Bioactivity
RI-AG03 is an orally active peptide inhibitor capable of crossing the blood-brain barrier, targeting Tau aggregation. It effectively inhibits Tau aggregation in both in vivo and in vitro models, improving associated neurodegenerative and behavioral phenotypes. RI-AG03 is applicable in research on Tauopathies such as Alzheimer's disease.
Molecular Formula
C104H189N49O22
Molecular Weight
2477.93
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6321217-01 0.2 mL
MLXIP, NT (MLXIP, BHLHE36, KIAA0867, MIR, MONDOA, MLX-interacting protein, Class E basic helix-loop-helix protein 36, Transcriptional activator MondoA) (PE)
Ask
View Details 
MBS6321217-02 5x 0.2 mL
MLXIP, NT (MLXIP, BHLHE36, KIAA0867, MIR, MONDOA, MLX-interacting protein, Class E basic helix-loop-helix protein 36, Transcriptional activator MondoA) (PE)
Ask
View Details 